Zobrazeno 1 - 10
of 48
pro vyhledávání: '"L.P. Danilova"'
Publikováno v:
РМЖ "Клиническая офтальмология", Vol 22, Iss 4 (2022)
N.S. Zhayvoronok1, O.V. Kolenko1–3, L.P. Danilova1,2, E.L. Sorokin1,3 1Khabarovsk Branch of the S. Fedorov Eye Microsurgery Federal State Institution, Khabarovsk, Russian Federation 2Institute of Advanced Training of Healthcare Specialists, K
Externí odkaz:
https://doaj.org/article/ed6565b72edf4181a35e2be53aba1b64
Autor:
G.P. Smoliakova, V.V. Egorov, L.P. Danilova, L.P. Emanova, D.А. Povalyaeva, N.S. Zhajvoronok, Е.V. Udovichenko
Publikováno v:
Modern technologies in ophtalmology. :312-316
Purpose. To evaluate clinical efficacy of using nutraceutical "Resvega Forte" in complex treatment neovascular age-related macular degeneration (nAMD) against the background anti-VEGF therapy using ranibizumab (LUCENTIS®). Material and methods. The
Publikováno v:
Modern technologies in ophtalmology. :339-343
Purpose. Evaluation clinical efficacy of complex treatment of optic neuritis (ON) associated with herpesvirus infection (HVI), including methods of immunotherapy. Material and methods. The clinical study involved 26 people (26 eyes) with acute ON ass
Publikováno v:
Modern technologies in ophtalmology. :204-207
Purpose. To assess the state of the choroid in patients with HLA-B27-associated anterior uveitis without detectable lesions of the macular zone by ophthalmoscopy. Material and methods. 22 patients with HLA-B27-associated acute anterior uveitis withou
Autor:
D.A. Povalyaeva, L.P. Danilova, L.P. Emanova, G.P. Smoliakova, E.V. Udovichenko, N.S. Zhaivoronok, V.V. Egorov
Publikováno v:
Modern technologies in ophtalmology. :163-166
Purpose. To evaluate efficacy of angiogenesis inhibitor ranibizumab (Lucentis, Novartis, Switzerland) in treatment of choroidal neovascularization (CNV) in patients with chronic central serous chorioretinopathy (CSCR). Material and methods. The objec
Autor:
G.P. Smoliakova, V.V. Egorov, Е.V. Udovichenko, L.P. Danilova, L.P. Emanova, N.S. Zhajvoronok, D.А. Povalyaeva
Publikováno v:
Modern technologies in ophtalmology. :153-157
Purpose. To evaluate the clinical efficacy of using the angiogenesis inhibitor aflibercept in combination with the nutraceutical «Resvega Forte» in the treatment of neovascular age-related macular degeneration (nAMD) Material and methods. The clini
Publikováno v:
Modern technologies in ophtalmology. :172-175
Purpose. To assess the state of the choroid in patients with anterior uveitis associated with the HLA-B27 Antigen, without ophthalmoscopically detectable lesions of the macular zone. Material and methods. 24 patients with acute anterior uveitis assoc
Autor:
D.А. Povalyaeva, V.V. Egorov, L.P. Danilova, G.P. Smoliakova, Е.V. Udovichenko, L.P. Emanova, N.S. Zhajvoronok
Publikováno v:
Modern technologies in ophtalmology. :167-171
Purpose. To study the clinical efficacy of complex treatment of optic neuritis (ON) associated with herpesvirus infection (HVI), including methods of immunotherapy. Material and methods. The clinical study involved 37 people (37 eyes) with acute ON a
Autor:
N.S. Zhaivoronok, L.P. Danilova, L.P. Emanova, E.V. Udovichenko, D.A. Povalyaeva, G.P. Smoliakova, V.V. Egorov
Publikováno v:
Modern technologies in ophtalmology. :158-162
Purpose. To study effectiveness combination of topical corticosteroid therapy and sulodexide in complex treatment of patients with isolated optic disk vasculitis (IODV). Material and methods. The study included 17 patients with IODV (middle age was 2
Autor:
L.P. Emanova, D.А. Povalyaeva, Е.V. Udovichenko, G.P. Smoliakova, V.V. Egorov, N.S. Zhajvoronok, L.P. Danilova
Publikováno v:
Modern technologies in ophtalmology. :199-203